Literature DB >> 31820920

Intravital Vascular Phototheranostics and Real-Time Circulation Dynamics of Micro- and Nanosized Erythrocyte-Derived Carriers.

Wangcun Jia1, Joshua M Burns2, Betty Villantay1, Jack C Tang2, Raviraj Vankayala3, Ben Lertsakdadet1, Bernard Choi1, J Stuart Nelson1, Bahman Anvari2.   

Abstract

Erythrocyte-based carriers can serve as theranostic platforms for delivery of imaging and therapeutic payloads. Engineering these carriers at micro- or nanoscales makes them potentially useful for broad clinical applications ranging from vascular diseases to tumor theranostics. Longevity of these carriers in circulation is important in delivering a sufficient amount of their payloads to the target. We have investigated the circulation dynamics of micro (∼4.95 μm diameter) and nano (∼91 nm diameter) erythrocyte-derived carriers in real time using near-infrared fluorescence imaging, and evaluated the effectiveness of such carrier systems in mediating photothermolysis of cutaneous vasculature in mice. Fluorescence emission half-lives of micro- and nanosized carriers in response to a single intravenous injection were ∼49 and ∼15 min, respectively. A single injection of microsized carriers resulted in a 3-fold increase in signal-to-noise ratio that remained nearly persistent over 1 h of imaging time. Our results also suggest that a second injection of the carriers 7 days later can induce a transient inflammatory response, as manifested by the apparent leakage of the carriers into the perivascular tissue. The administration of the carriers into the mice vasculature reduced the threshold laser fluence to induce photothermolysis of blood vessels from >65 to 20 J/cm2. We discuss the importance of membrane physicochemical and mechanical characteristics in engineering erythrocyte-derived carriers and considerations for their clinical translation.

Entities:  

Keywords:  cancer; delivery systems; erythrocyte engineering; laser dermatologic surgery; near-infrared imaging; phototherapy; port wine stain

Mesh:

Substances:

Year:  2019        PMID: 31820920      PMCID: PMC7028219          DOI: 10.1021/acsami.9b18624

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  72 in total

Review 1.  Red blood cells as carriers of iron oxide-based contrast agents for diagnostic applications.

Authors:  Antonella Antonelli; Mauro Magnani
Journal:  J Biomed Nanotechnol       Date:  2014-09       Impact factor: 4.099

2.  Near-Infrared-Fluorescent Erythrocyte-Mimicking Particles: Physical and Optical Characteristics.

Authors:  Jack C Tang; Allen Partono; Bahman Anvari
Journal:  IEEE Trans Biomed Eng       Date:  2018-08-20       Impact factor: 4.538

3.  Lactadherin binds to phosphatidylserine-containing vesicles in a two-step mechanism sensitive to vesicle size and composition.

Authors:  Daniel E Otzen; Kristine Blans; Huabing Wang; Gary E Gilbert; Jan T Rasmussen
Journal:  Biochim Biophys Acta       Date:  2011-09-02

Review 4.  Nanoparticle PEGylation for imaging and therapy.

Authors:  Jesse V Jokerst; Tatsiana Lobovkina; Richard N Zare; Sanjiv S Gambhir
Journal:  Nanomedicine (Lond)       Date:  2011-06       Impact factor: 5.307

5.  Bovine PAS-6/7 binds alpha v beta 5 integrins and anionic phospholipids through two domains.

Authors:  M H Andersen; L Berglund; J T Rasmussen; T E Petersen
Journal:  Biochemistry       Date:  1997-05-06       Impact factor: 3.162

6.  Erythrocyte-Derived Theranostic Nanoplatforms for Near Infrared Fluorescence Imaging and Photodestruction of Tumors.

Authors:  Joshua M Burns; Raviraj Vankayala; Jenny T Mac; Bahman Anvari
Journal:  ACS Appl Mater Interfaces       Date:  2018-08-09       Impact factor: 9.229

7.  Microvascular endothelial cells express a phosphatidylserine receptor: a functionally active receptor for phosphatidylserine-positive erythrocytes.

Authors:  B N Yamaja Setty; Suhita Gayen Betal
Journal:  Blood       Date:  2007-10-02       Impact factor: 22.113

8.  Optical properties of biomimetic probes engineered from erythrocytes.

Authors:  Joshua M Burns; Rolf Saager; Boris Majaron; Wangcun Jia; Bahman Anvari
Journal:  Nanotechnology       Date:  2016-12-14       Impact factor: 3.874

9.  ATP11C is a major flippase in human erythrocytes and its defect causes congenital hemolytic anemia.

Authors:  Nobuto Arashiki; Yuichi Takakuwa; Narla Mohandas; John Hale; Kenichi Yoshida; Hiromi Ogura; Taiju Utsugisawa; Shouichi Ohga; Satoru Miyano; Seishi Ogawa; Seiji Kojima; Hitoshi Kanno
Journal:  Haematologica       Date:  2016-03-04       Impact factor: 9.941

10.  Transmembrane redistribution of phospholipids of the human red cell membrane during hypotonic hemolysis.

Authors:  S L Schrier; A Zachowski; P Hervé; J C Kader; P F Devaux
Journal:  Biochim Biophys Acta       Date:  1992-03-23
View more
  2 in total

Review 1.  Cell Membrane-Cloaked Nanotherapeutics for Targeted Drug Delivery.

Authors:  Na-Hyun Lee; Sumin You; Ali Taghizadeh; Mohsen Taghizadeh; Hye Sung Kim
Journal:  Int J Mol Sci       Date:  2022-02-17       Impact factor: 5.923

Review 2.  Phototheranostics Using Erythrocyte-Based Particles.

Authors:  Taylor Hanley; Raviraj Vankayala; Chi-Hua Lee; Jack C Tang; Joshua M Burns; Bahman Anvari
Journal:  Biomolecules       Date:  2021-05-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.